| Metric | Q2'25 | Q3'25 | Change |
|---|---|---|---|
| Revenue | $97.9M (down 4% YoY) | $96.1M (up 1% YoY) | Sequential decline of 2% |
| Endpoint IC Revenue | $84.6M (down 5% YoY) | $78.8M (down 3% YoY) | 7% sequential decline despite 'record volumes' |
| Systems Revenue | $13.3M (up 1% YoY) | $17.3M (up 21% YoY) | +30% sequential surge |
| Gross Margin | 60.4% | 53.0% | 740 bps compression from licensing impact |
| Product Gross Margin (ex-licensing) | 52.6% | ~52.2% (implied) | +40 bps sequential improvement |
| Adjusted EBITDA | $27.6M | $19.1M | 31% sequential decline |
| Adjusted EBITDA Margin | 28.2% | 19.8% | Record on product revenue basis |
| Non-GAAP EPS | $0.80 | $0.58 | 28% sequential decline |
| Operating Expense | $31.5M | $31.8M | +$0.3M with 'good fiscal discipline' |
| Cash & Investments | $260.5M | $265.1M | +$4.6M despite convertible swap |
Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.
Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.